Target
— → $122.86
Conviction●○○○○1 of 5
Research target$122.86Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed 7/8/26
Market cap$12.69BSnapshot value
Research history
See all RVTY changes ↗What changed
Last reviewed
Not reviewed → 7/8/26
Target
— → $122.86
Reagents + proteogenomics pure-play. BioLegend (antibodies/reagents) + TotalSeq (multi-omics) + newborn screening installed base. Recurring reagent pull is the moat.
Multi-omics adoption driving reagent demand; newborn screening franchise expansion; proteogenomics integration tailwind.
Reagent commoditization risk; competitive pressure from larger players (Thermo, Danaher); academic budget sensitivity.
needs X/Reddit sentiment sweep
Snapshot · 7/8/26🟢 Lean-Bull · ins-$0.2M · 13F 15+/10- · short↑0.21
Snapshot · 7/8/26